| Company | Date | Position | Consensus ⓘ | Price Target ⓘ | 1-Yr Return |
|---|---|---|---|---|---|
|
MRK
Merck & Company
|
Apr 17, 2026 | BUY |
Strong Buy
+10.7% avg upside
43 analysts
|
$179.00
57.24% Upside
|
-2.4% |
|
RGEN
Repligen
|
Apr 17, 2026 | BUY |
Strong Buy
+28.4% avg upside
25 analysts
|
$160.00
21.19% Upside
|
-6.8% |
|
TMO
Thermo Fisher
|
Apr 17, 2026 | BUY |
Strong Buy
+26.8% avg upside
38 analysts
|
$620.00
33.50% Upside
|
-12.2% |
|
DE:SRT3
Sartorius
|
Apr 17, 2026 | BUY |
Buy
+27.9% avg upside
17 analysts
|
$285.00
33.86% Upside
|
· |
|
BRKR
Bruker
|
Nov 20, 2025 | BUY |
Buy
-7.0% avg upside
22 analysts
|
$60.00
4.79% Upside
|
+25.2% |
|
WAT
Waters
|
Oct 08, 2025 | BUY |
Strong Buy
+3.6% avg upside
30 analysts
|
$390.00
9.66% Upside
|
+9.0% |
|
A
Agilent
|
Oct 08, 2025 | BUY |
Strong Buy
+3.8% avg upside
32 analysts
|
$165.00
29.91% Upside
|
-11.3% |
Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.